These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16672091)

  • 1. Changes in expression of p53, proliferating cell nuclear antigen and bcl-2 in recurrent laryngeal cancer after radiotherapy.
    Lee BJ; Wang SG; Roh HJ; Goh EK; Chon KM; Park DY
    J Laryngol Otol; 2006 Jul; 120(7):579-82. PubMed ID: 16672091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?
    Plastiras D; Moutzouris G; Barbatis C; Presvelos V; Petrakos M; Theodorou C
    Eur J Surg Oncol; 1999 Feb; 25(1):61-5. PubMed ID: 10188857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53, epidermal growth factor receptor and proliferating cell nuclear antigen in laryngeal squamous cell carcinoma are not predictive markers for the effect of adjuvant radiotherapy.
    Jiang H; Yang BB
    Acta Otolaryngol; 2009 Jan; 129(1):101-7. PubMed ID: 18607952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of proliferating cell nuclear antigen and bcl-2 expression with tumor front grading and metastasis in laryngeal squamous cell carcinoma.
    Boran C; Yildiz L; Kandemir B; Karagoz F; Baris S; Aydin O
    Neoplasma; 2003; 50(2):139-43. PubMed ID: 12740649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
    Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
    Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 and proliferating cell nuclear antigen (PCNA) expression correlates with subsequent local recurrence in nasopharyngeal carcinomas.
    Tsai ST; Jin YT; Leung HW; Wang ST; Tsao CJ; Su IJ
    Anticancer Res; 1998; 18(4B):2849-54. PubMed ID: 9713473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein expression of p53 and Bcl-2 has a strong correlation with radiation resistance of laryngeal squamous cell carcinoma but does not predict the radiation failure before treatment.
    Ogawa T; Shiga K; Tateda M; Saijo S; Suzuki T; Sasano H; Miyagi T; Kobayashi T
    Oncol Rep; 2003; 10(5):1461-6. PubMed ID: 12883724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of apoptotic and proliferation markers in meningiomas.
    Konstantinidou AE; Pavlopoulos PM; Patsouris E; Kaklamanis L; Davaris P
    J Pathol; 1998 Nov; 186(3):325-30. PubMed ID: 10211124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer.
    Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD
    J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of p53 expression in the primary lesion and the surgical margin on the postoperative radiotherapy for laryngeal squamous carcinoma].
    Xia LP; Zeng ZY; Guo ZM; Rao HL; Zeng J; Xu GP; Hou JH
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):558-61. PubMed ID: 14690561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ki-67 and p53 expression as prognosticators of clinical course aggressiveness of squamous cell cancer of the larynx].
    Gorban' NA; Ten VP; Pankratov VA
    Vopr Onkol; 2007; 53(6):668-73. PubMed ID: 18416135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of PCNA, p53, Bax, and Bcl-X in oral poorly differentiated and basaloid squamous cell carcinoma: relationships with prognosis.
    Sampaio-Góes FC; Oliveira DT; Dorta RG; Nonogaki S; Landman G; Nishimoto IN; Kowalski LP
    Head Neck; 2005 Nov; 27(11):982-9. PubMed ID: 16136583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
    Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
    Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioresistance and p53 status of T2 laryngeal carcinoma. Analysis by immunohistochemistry and denaturing gradient gel electrophoresis.
    Kropveld A; Slootweg PJ; van Mansfeld AD; Blankenstein MA; Hordijk GJ
    Cancer; 1996 Sep; 78(5):991-7. PubMed ID: 8780536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?
    Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M
    Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of the immunohistochemical expression of: Ki67, p53, PCNA and Bcl2 in the superficial tumors of the bladder].
    Rammeh-Rommani S; Zermani R; Sfaxi M; Chabchoub A; Zouari B; Ayed M; Ben Jilani-Baltagi S
    Tunis Med; 2007 Jun; 85(6):509-12. PubMed ID: 17644907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy.
    Holgersson G; Ekman S; Reizenstein J; Bergqvist M; Pontén F; Uhlén M; Magnusson K; Jonnalagadda P; Asplund A; Strömberg S; Linder A; Blomquist E; Liljeholm M; Lödén B; Hellström K; Bergström S
    Cancer Genomics Proteomics; 2010; 7(1):1-7. PubMed ID: 20181625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
    de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
    Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.